Cargando…
Ovarian cancer mutational processes drive site-specific immune evasion
High-grade serous ovarian cancer (HGSOC) is an archetypal cancer of genomic instability(1–4) patterned by distinct mutational processes(5,6), tumour heterogeneity(7–9) and intraperitoneal spread(7,8,10). Immunotherapies have had limited efficacy in HGSOC(11–13), highlighting an unmet need to assess...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771812/ https://www.ncbi.nlm.nih.gov/pubmed/36517593 http://dx.doi.org/10.1038/s41586-022-05496-1 |